It is with great pleasure we can announce Dr. Jan Hendrik Egberts has been appointed Chairman of the Supervisory Board, effective 1 May 2016.
Jan joins Mellon with significant senior management experience, holding over 10 executive and non-executive supervisory board positions in the USA and various European countries in the venture capital, specialty pharmaceutical and medical device sectors.
His many corporate management positions have included CEO of the specialty pharmaceutical company OctoPlus, which was acquired in 2013 by India-based Dr. Reddy’s Laboratories Ltd.; Chairman of the Board of Endosense, a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation that was purchased by St. Jude Medical in 2013; Chairman of Molnlycke Healthcare Inc. and President of Molnlycke’s BARRIER Surgical division; and Vice President of worldwide business and market development as well as a Global Executive Board member for Johnson & Johnson Medical.
Jan graduated from Erasmus University Medical School in the Netherlands and pursued his clinical training at Harvard Medical School. He obtained his MBA from Stanford.